Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Extradition process...

    Extradition process against 4 Sterling Biotech promoters initiated: ED tells court

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-01-22T13:17:28+05:30  |  Updated On 22 Jan 2019 1:17 PM IST
    Extradition process against 4 Sterling Biotech promoters initiated: ED tells court
    The ED told the court that the four accused are reported to be in Italy and Nigeria and their extradition is required for probing the case.

    NEW DELHI: The Enforcement Directorate Monday informed a Delhi court that it has initiated extradition process against four Sterling Biotech promoters in the Rs 8,100 crore bank fraud case.


    The agency made the submissions before Additional Sessions Judge Satish Kumar Arora and sought the court's certification of the process against Sterling Biotech Ltd (SBL) promoters Nitin Jayantilal Sandesara, Chetankumar Jayantilal Sandesara, Dipti Chetan Sandesara and Hiteshkumar Narendrabhai Patel.


    Read Also: Rs 8100 crore bank loan fraud case: Sterling Biotech receives non bailable warrants

    The ED told the court that the four accused are reported to be in Italy and Nigeria and their extradition is required for probing the case.


    The agency has registered the alleged bank fraud case against the firm SBL under sections of the Prevention of Money Laundering Act (PMLA).


    The court had earlier this month issued open-ended non-bailable warrants against the four promoters of the Gujarat pharma firm in the case.


    The accused are being probed by the agency also for allegedly bribing senior income tax department officials as part of an earlier criminal complaint.


    The ED had on December 24, 2018, informed the court that it wanted to approach the Interpol for the issuance of Red Corner Notice (RCN) against the SBL's directors.


    Read Also: Sterling Biotech bank fraud case,ED attaches property worth 4700 crores

    The agency's special public prosecutor Nitesh Rana had told the court that the Interpol guidelines for opening RCN against the four accused persons required open-ended NBWs from the court.


    An "open-ended NBW" does not carry a time limit for execution, unlike non-bailable warrants.


    The ED had earlier told the court that the accused persons have left the country under suspicious circumstances and evaded the process of law to face criminal prosecution and that they were "shifting countries to escape the clutches of the law".


    The court had earlier issued NBW against all the four accused which could not be executed because of the "unavailability of the aforesaid concerned persons".


    The agency has also attached a number of properties belonging to the accused and a charge sheet was filed against them and others.


    The ED had told the court that it was suspected that the accused were in Nigeria, the United States or the United Arab Emirates because they have extensive business interests in these countries.


    Read Also: Delhi court issues notices to Sterling Biotech owners in Rs 8,100 crore bank loan fraud case

    allegedlyChetankumar Jayantilal SandesaraDelhi CourtDipti Chetan SandesaraEDEnforcement DirectoratefraudHiteshkumar Narendrabhai Patel.initiated extradition processJudge Satish Kumar AroraNew DelhiNitin Jayantilal SandesaraNon-bailable warrantsPharmaceutical industryPMLAPrevention of Money Laundering ActRCNRed Corner NoticeSBLSBL promotersSterling BiotechSterling Biotech LtdUnited Arab EmiratesUnited States
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok